Hyaluronic Acid Eye Drops 0.1% (Olopatadine Hydrochloride)
Olopatadine Hydrochloride 1.11mg
Eye drops · Prescription medication
Huons Co., Ltd.
MFDS item code 202004121 · Approved 2020.05.29 · Insurance code 670608551
Relief of symptoms associated with allergic conjunctivitis
Allergic conjunctivitis is a condition that causes itchy eyes, redness, and tearing. This medication helps alleviate symptoms caused by allergic conjunctivitis and reduces eye discomfort. It effectively improves symptoms to prevent interference with daily life. It can be used safely to protect eye health. Therefore, it is used for the treatment of symptoms of allergic conjunctivitis.
Instill 1 drop twice a day (every 6 to 8 hours). Treatment may be continued for a maximum of 4 months if necessary.
This medication should not be used by individuals who are allergic to the active ingredient or any of the components of this medication. While using this medication, headaches or abnormal taste may occur, and occasional dizziness may be reported. Eye symptoms such as punctate keratitis, keratitis, eye pain, dryness, swelling, itching, discharge, redness, and eyelid skin changes can occur with some frequency. Additionally, light sensitivity, blurred vision, and eyelid redness may rarely occur. Dryness of the nose or symptoms of rhinitis may occur infrequently, and dry mouth may also be present. There is a possibility of contact dermatitis on the skin. Fatigue may be experienced. Occasionally, increased eye sensitivity or symptoms of weakness, cold symptoms, nausea, pharyngitis, sinusitis, skin rashes, abdominal pain, liver dysfunction, jaundice, increased blood pressure, decreased white blood cells, and difficulty urinating have been reported. This medication contains phosphate, which may very rarely result in calcification of the cornea in patients with severe corneal damage. This is a non-sedating antihistamine, and vision may temporarily blur after use, so do not drive or operate machinery while experiencing blurred vision; wait until your vision becomes clear. Patients receiving long-term steroid therapy should reduce the steroid dose gradually under a doctor's supervision when using this medication. In cases of seasonal allergies, it is advisable to start using this medication before symptoms begin and continue until symptoms resolve. If no effect is observed, it is better not to use it for an extended period. The benzalkonium chloride contained in this medication may cause eye irritation and discoloration of soft contact lenses; therefore, do not wear lenses during use, and wear lenses at least 15 minutes after instillation. It is advisable to avoid wearing contact lenses when experiencing eye redness. Safety during pregnancy has not been fully established; use this medication cautiously according to a doctor's instructions. If breastfeeding, discuss using this medication with a doctor beforehand as it may be excreted in breast milk, considering the effect on the infant. Safety and efficacy in children under three years of age have not been established. No special dosing adjustments are necessary for elderly patients. In case of overdose, immediate medical observation and treatment are required. When using, be careful not to let the tip of the bottle come into direct contact with the eye, and when using other eye drops, maintain a minimum interval of 5 minutes between administrations; if using ointments, they should be applied last. Store this medication away from direct sunlight in a cool place, keeping it out of reach of children.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in an opaque container. Additionally, it is important to store it at a temperature between 4 degrees and 25 degrees Celsius to maintain the drug's effectiveness.
A colorless to pale yellow liquid contained in an opaque white plastic bottle for eye drops
6 milliliters/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Olopatadine Hydrochloride 1.11mg
Eye drops · Prescription medication
Huons Co., Ltd.
Olopatadine Hydrochloride 1.11mg
Eye drops · Prescription medication
Novartis Korea Co., Ltd.
Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
Korea Kyowa Kirin Co., Ltd.
Olopatadine Hydrochloride 2.22mg
Eye drops · Prescription medication
Novartis Korea Co., Ltd.

Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
International Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.